Garry Arthur Neil - 09 Dec 2022 Form 4 Insider Report for Avalo Therapeutics, Inc. (AVTX)

Role
CEO and Chairman of the Board, Director
Signature
/s/ Christopher Sullivan, by Power of Attorney
Issuer symbol
AVTX
Transactions as of
09 Dec 2022
Net transactions value
+$9,207
Form type
4
Filing time
12 Dec 2022, 15:22:14 UTC
Previous filing
07 Oct 2022
Next filing
15 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AVTX Common Stock Purchase $9,207 +2,083 +29% $4.42* 9,220 09 Dec 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were acquired under the Issuer's 2016 Employee Stock Purchase Plan.